Artivion Announces Presentation of Late-Breaking Data from AMDS PERSEVERE Trial at the 61st Society of...
Artivion Granted FDA Humanitarian Device Exemption for the AMDS Hybrid Prosthesis PR Newswire ATLANTA, Dec. 9...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads